Ascend Life Science (als) Ltd - Accounts

Ascend Life Science (als) Ltd - Accounts

ASCEND MEDICAL TECHNOLOGY (UK) LTD - Company Information

Print Friendly Version

Ascend Life Science (als) Ltd 11083185 Machinery Sales false 27 November 2017 11083185 2017-11-27 2018-11-30 11083185 2017-11-26 11083185 2018-11-30 11083185 frs102-bus:FRS102 2017-11-27 2018-11-30 11083185 frs102-bus:PrivateLimitedCompanyLtd 2017-11-27 2018-11-30 11083185 frs102-bus:FullAccounts 2017-11-27 2018-11-30 11083185 frs102-bus:AuditExemptWithAccountantsReport 2017-11-27 2018-11-30 11083185 frs102-bus:LeadAgentIfApplicable 2017-11-27 2018-11-30 11083185 frs102-core:ShareCapital 2018-11-30 11083185 frs102-bus:Director1 2017-11-27 2018-11-30 11083185 frs102-bus:OrdinaryShareClass1 2018-11-30 11083185 frs102-bus:OrdinaryShareClass1 2017-11-27 2018-11-30 xbrli:pure iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares
Registered number
11083185
Ascend Life Science (als) Ltd
Unaudited Accounts
for the period
27 November 2017 to 30 November 2018

Ascend Life Science (als) Ltd
Accountant's Report

Report to the directors on the preparation of the unaudited statutory accounts of Ascend Life Science (als) Ltd for the period ended 30 November 2018.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Ascend Life Science (als) Ltd for the period ended 30 November 2018 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://rulebook.accaglobal.com



................................

PAH Accounting
Chartered Certified Accountants

Unit 2, The Pound,
Coate,
Devizes,
Wiltshire,
SN10 3LG

18 June 2019


Ascend Life Science (als) Ltd
Balance Sheet
as at 30 November 2018
Notes
 2018
£
Net current assets / (liabilities) 100
Total assets less current liabilities 100
Total net assets (liabilities) 100
Capital and reserves
Called up share capital 2 100
Shareholders' funds 100

Ascend Life Science (als) Ltd
Balance Sheet
as at 30 November 2018



These accounts have been prepared and delivered in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

The directors have not delivered a copy of the company's Profit and Loss account as permitted by s444(5A) of the Companies Act 2006.

For the year ending 30 November 2018 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Signed on behalf of the board of directors

...............................

Mr N Hircock

Director


Approved by the board on 18 June 2019

Company Number: 11083185 (a Private Company Limited by Shares registered in England and Wales)

Registered Office:

Unit 2 The Pound
Coate
Devizes
Wiltshire
SN10 3LG
England

Ascend Life Science (als) Ltd
Notes to the Accounts
for the period 27 November 2017 to 30 November 2018

1. Accounting policies

Basis of preparation of financial statements
These financial statements have been prepared under the historic cost convention in accordance with the accounting policies set out below and with section 1A of FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland, and the Companies Act 2006. The presentation currency is sterling.
2. Share capital
2018
£
Allotted, called up and fully paid:
100 Ordinary shares of £1.00 each 100
100

3. Related party disclosures

Controlling party
The company is controlled by Mr Nigel Hircock and Mr Ronny Bijron, by virtue of equal shareholding.